206 related articles for article (PubMed ID: 31041750)
1. Analysis of IL-4/STAT6 Signaling in Macrophages.
Waqas SFH; Ampem G; Röszer T
Methods Mol Biol; 2019; 1966():211-224. PubMed ID: 31041750
[TBL] [Abstract][Full Text] [Related]
2. TRAF6 promotes IL-4-induced M2 macrophage activation by stabilizing STAT6.
Zhou C; Lu C; Pu H; Li D; Zhang L
Mol Immunol; 2020 Nov; 127():223-229. PubMed ID: 33017719
[TBL] [Abstract][Full Text] [Related]
3. Macrophage alternative activation confers protection against lipotoxicity-induced cell death.
Dai L; Bhargava P; Stanya KJ; Alexander RK; Liou YH; Jacobi D; Knudsen NH; Hyde A; Gangl MR; Liu S; Lee CH
Mol Metab; 2017 Oct; 6(10):1186-1197. PubMed ID: 29031719
[TBL] [Abstract][Full Text] [Related]
4. The Transcription Factor STAT6 Mediates Direct Repression of Inflammatory Enhancers and Limits Activation of Alternatively Polarized Macrophages.
Czimmerer Z; Daniel B; Horvath A; Rückerl D; Nagy G; Kiss M; Peloquin M; Budai MM; Cuaranta-Monroy I; Simandi Z; Steiner L; Nagy B; Poliska S; Banko C; Bacso Z; Schulman IG; Sauer S; Deleuze JF; Allen JE; Benko S; Nagy L
Immunity; 2018 Jan; 48(1):75-90.e6. PubMed ID: 29343442
[TBL] [Abstract][Full Text] [Related]
5. Src promotes anti-inflammatory (M2) macrophage generation via the IL-4/STAT6 pathway.
Hu X; Wang H; Han C; Cao X
Cytokine; 2018 Nov; 111():209-215. PubMed ID: 30176559
[TBL] [Abstract][Full Text] [Related]
6. Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands
Liang CL; Jiang H; Feng W; Liu H; Han L; Chen Y; Zhang Q; Zheng F; Lu CJ; Dai Z
Front Immunol; 2021; 12():683249. PubMed ID: 34290705
[TBL] [Abstract][Full Text] [Related]
7. Metabolic Reprogramming Mediated by the mTORC2-IRF4 Signaling Axis Is Essential for Macrophage Alternative Activation.
Huang SC; Smith AM; Everts B; Colonna M; Pearce EL; Schilling JD; Pearce EJ
Immunity; 2016 Oct; 45(4):817-830. PubMed ID: 27760338
[TBL] [Abstract][Full Text] [Related]
8. The IL-4/STAT6 signaling axis establishes a conserved microRNA signature in human and mouse macrophages regulating cell survival via miR-342-3p.
Czimmerer Z; Varga T; Kiss M; Vázquez CO; Doan-Xuan QM; Rückerl D; Tattikota SG; Yan X; Nagy ZS; Daniel B; Poliska S; Horvath A; Nagy G; Varallyay E; Poy MN; Allen JE; Bacso Z; Abreu-Goodger C; Nagy L
Genome Med; 2016 May; 8(1):63. PubMed ID: 27245778
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of Corilagin interference with IL-13/STAT6 signaling pathways in hepatic alternative activation macrophages in schistosomiasis-induced liver fibrosis in mouse model.
Du P; Ma Q; Zhu ZD; Li G; Wang Y; Li QQ; Chen YF; Shang ZZ; Zhang J; Zhao L
Eur J Pharmacol; 2016 Dec; 793():119-126. PubMed ID: 27845069
[TBL] [Abstract][Full Text] [Related]
10. Runx1 Deficiency Promotes M2 Macrophage Polarization Through Enhancing STAT6 Phosphorylation.
Zhou S; Zhao T; Chen X; Zhang W; Zou X; Yang Y; Wang Q; Zhang P; Zhou T; Feng T
Inflammation; 2023 Dec; 46(6):2241-2253. PubMed ID: 37530929
[TBL] [Abstract][Full Text] [Related]
11. Extensive and functional overlap of the STAT6 and RXR cistromes in the active enhancer repertoire of human CD14+ monocyte derived differentiating macrophages.
Czimmerer Z; Nagy ZS; Nagy G; Horvath A; Silye-Cseh T; Kriston A; Jonas D; Sauer S; Steiner L; Daniel B; Deleuze JF; Nagy L
Mol Cell Endocrinol; 2018 Aug; 471():63-74. PubMed ID: 28774779
[TBL] [Abstract][Full Text] [Related]
12. The interleukin 13 (IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor alpha1 (IL13Ralpha1).
Martinez-Nunez RT; Louafi F; Sanchez-Elsner T
J Biol Chem; 2011 Jan; 286(3):1786-94. PubMed ID: 21097505
[TBL] [Abstract][Full Text] [Related]
13. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
14. Suppressor of cytokine signaling-1 is an IL-4-inducible gene in macrophages and feedback inhibits IL-4 signaling.
Dickensheets H; Vazquez N; Sheikh F; Gingras S; Murray PJ; Ryan JJ; Donnelly RP
Genes Immun; 2007 Jan; 8(1):21-7. PubMed ID: 17093501
[TBL] [Abstract][Full Text] [Related]
15. IL-4/STAT6 signaling facilitates innate hematoma resolution and neurological recovery after hemorrhagic stroke in mice.
Xu J; Chen Z; Yu F; Liu H; Ma C; Xie D; Hu X; Leak RK; Chou SHY; Stetler RA; Shi Y; Chen J; Bennett MVL; Chen G
Proc Natl Acad Sci U S A; 2020 Dec; 117(51):32679-32690. PubMed ID: 33293423
[TBL] [Abstract][Full Text] [Related]
16. Transcription factors STAT6 and KLF4 implement macrophage polarization via the dual catalytic powers of MCPIP.
Kapoor N; Niu J; Saad Y; Kumar S; Sirakova T; Becerra E; Li X; Kolattukudy PE
J Immunol; 2015 Jun; 194(12):6011-23. PubMed ID: 25934862
[TBL] [Abstract][Full Text] [Related]
17. Sphingosine 1-phosphate induced anti-atherogenic and atheroprotective M2 macrophage polarization through IL-4.
Park SJ; Lee KP; Kang S; Lee J; Sato K; Chung HY; Okajima F; Im DS
Cell Signal; 2014 Oct; 26(10):2249-58. PubMed ID: 25035231
[TBL] [Abstract][Full Text] [Related]
18. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression.
Dickensheets HL; Venkataraman C; Schindler U; Donnelly RP
Proc Natl Acad Sci U S A; 1999 Sep; 96(19):10800-5. PubMed ID: 10485906
[TBL] [Abstract][Full Text] [Related]
19. CD137 signaling induces macrophage M2 polarization in atherosclerosis through STAT6/PPARδ pathway.
Geng T; Yan Y; Xu L; Cao M; Xu Y; Pu J; Yan JC
Cell Signal; 2020 Aug; 72():109628. PubMed ID: 32247042
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Stat6 pathway in tumor-associated macrophages reduces tumor growth and metastatic niche formation in breast cancer.
Binnemars-Postma K; Bansal R; Storm G; Prakash J
FASEB J; 2018 Feb; 32(2):969-978. PubMed ID: 29066614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
